RxDoctor Payments Data

Melissa Frederick

Nurse Practitioner · West Liberty, KYNPI 1629180690

Payments from drug & device makers

$950in general payments, 2019–2025

Across 52 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$264
  • Novo Nordisk$160
  • Lilly USA, LLC$103
  • Pfizer$88
  • AbbVie$88
  • Sanofi-aventis U.S. LLC$69
  • plus $177 from 8 others

What the payments were for

  • Food & beverage$950100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$950 in reported general payments places this provider in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$526
Medicare patients
15
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide69$67,695
JardianceEmpagliflozin72$56,883
MounjaroTirzepatide51$52,904
JanuviaSitagliptin Phosphate52$42,336
FarxigaDapagliflozin Propanediol57$42,168
EliquisApixaban52$36,440
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog36$22,780
TrulicityDulaglutide14$21,965
TradjentaLinagliptin28$20,813
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$17,299
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl485$17,167
Breo ElliptaFluticasone/Vilanterol29$13,852
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$12,343
LinzessLinaclotide16$10,803
BrilintaTicagrelor21$9,580

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humulin 70-30$103$77,03080 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$44$72,284117 claims
Novo NordiskOzempic$160$67,69569 claims
PfizerEliquis, Premarin$88$40,19570 claims
GSKTrelegy Ellipta, Breo Ellipta$264$31,15148 claims
AbbVieLinzess$88$10,80316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in West Liberty

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →